Klarity Health works with many insurance plans across Arizona
While uncommon, people have reported this condition while taking semaglutide
In a diabetes-specific population (TRANSCEND-T2D-1, 40 weeks), weight loss was 16.8% substantially lower, consistent with GLP-1 class patterns
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial
Lillys Phase II clinical trial results, published in the New England Journal of Medicine, demonstrate that orforglipron achieved up to a 14.7% mean weight reduction at 36 weeks in adults with obesity or overweight
She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.